aristolochic acid i has been researched along with Carcinoma, Transitional Cell in 28 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Balkan endemic nephropathy is a chronic tubulointerstitial disease with insidious onset, slowly progressing to end-stage renal disease and frequently associated with urothelial carcinoma of the upper urinary tract (UTUC)." | 2.61 | Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid. ( Arlt, VM; Colet, JM; Dika, Ž; Jelaković, B; Nikolić, J; Nortier, JL; Pavlović, NM; Stiborova, M; Vanherweghem, JL, 2019) |
| "UTUC and bladder cancer share some common risk factors, even if they are two different entities regarding practical, biological and clinical characteristics." | 2.55 | Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). ( Babjuk, M; Chade, DC; Fernández, MI; Fritsche, HM; Grollman, AP; Kassouf, W; Kikuchi, E; Lerner, SP; Lotan, Y; Rink, M; Shariat, SF; Soria, F; Spiess, PE; Thalmann, GN; Ye, D, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 10 (35.71) | 24.3611 |
| 2020's | 8 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Karanović, S | 1 |
| Ardin, M | 1 |
| Tang, Z | 1 |
| Tomić, K | 1 |
| Villar, S | 1 |
| Renard, C | 1 |
| Venturini, E | 1 |
| Lorch, AH | 1 |
| Lee, DS | 1 |
| Stipančić, Ž | 1 |
| Slade, N | 2 |
| Vuković Brinar, I | 1 |
| Dittrich, D | 1 |
| Karlović, K | 1 |
| Borovečki, F | 1 |
| Dickman, KG | 4 |
| Olivier, M | 1 |
| Grollman, AP | 6 |
| Jelaković, B | 3 |
| Zavadil, J | 2 |
| Thangavelu, M | 1 |
| Ismail, A | 1 |
| Zakaria, A | 1 |
| Elmansy, H | 1 |
| Shahrour, W | 1 |
| Prowse, O | 1 |
| Kotb, A | 1 |
| Chen, CH | 4 |
| Pu, YS | 4 |
| Li, S | 1 |
| Zhang, J | 2 |
| Tian, Y | 2 |
| Zhu, Y | 1 |
| Guo, Y | 1 |
| Wang, Z | 1 |
| Yang, Y | 1 |
| Ding, G | 1 |
| Lin, J | 1 |
| Komatsu, M | 1 |
| Funakoshi, T | 1 |
| Aki, T | 1 |
| Unuma, K | 1 |
| Uemura, K | 1 |
| Jhuang, JR | 1 |
| Chiu, PC | 1 |
| Hsieh, TC | 1 |
| Lee, WC | 1 |
| Liao, CI | 1 |
| Fang, HC | 1 |
| Lee, PT | 1 |
| Hsu, CY | 1 |
| Chen, CL | 1 |
| Huang, CW | 1 |
| Chen, XY | 1 |
| Ou, SH | 1 |
| Tsai, CT | 1 |
| Chou, KJ | 1 |
| Radic Savic, Z | 1 |
| Coric, V | 1 |
| Vidovic, S | 1 |
| Vidovic, V | 1 |
| Becarevic, J | 1 |
| Milovac, I | 1 |
| Reljic, Z | 1 |
| Mirjanic-Azaric, B | 1 |
| Skrbic, R | 1 |
| Gajanin, R | 1 |
| Matic, M | 1 |
| Simic, T | 1 |
| Shao, IH | 1 |
| Chang, YH | 1 |
| Pang, ST | 1 |
| Dika, Ž | 1 |
| Arlt, VM | 2 |
| Stiborova, M | 1 |
| Pavlović, NM | 1 |
| Nikolić, J | 1 |
| Colet, JM | 1 |
| Vanherweghem, JL | 2 |
| Nortier, JL | 2 |
| Fang, D | 1 |
| Zhang, L | 3 |
| Li, X | 1 |
| Xiong, G | 1 |
| Chen, X | 1 |
| Han, W | 1 |
| He, Z | 1 |
| Zhou, L | 2 |
| Zhang, A | 1 |
| Shang, D | 1 |
| Shi, R | 1 |
| Fu, F | 1 |
| Soria, F | 1 |
| Shariat, SF | 1 |
| Lerner, SP | 1 |
| Fritsche, HM | 1 |
| Rink, M | 1 |
| Kassouf, W | 1 |
| Spiess, PE | 1 |
| Lotan, Y | 1 |
| Ye, D | 1 |
| Fernández, MI | 1 |
| Kikuchi, E | 1 |
| Chade, DC | 1 |
| Babjuk, M | 1 |
| Thalmann, GN | 1 |
| Yuan, M | 1 |
| Shi, YB | 1 |
| Li, ZH | 1 |
| Xia, M | 1 |
| Ji, GZ | 1 |
| Xu, GX | 1 |
| Han, Y | 1 |
| Stefanovic, V | 1 |
| Polenakovic, M | 1 |
| Toncheva, D | 1 |
| Moriya, M | 3 |
| Sidorenko, VS | 1 |
| Edwards, KL | 1 |
| Gnatenko, DV | 1 |
| Wu, L | 2 |
| Turesky, RJ | 2 |
| Wu, XR | 1 |
| Schetter, AJ | 1 |
| Harris, CC | 1 |
| Cao, YL | 1 |
| Li, WG | 1 |
| Fu, FT | 1 |
| Wang, X | 1 |
| Shi, XH | 1 |
| Huang, CY | 1 |
| Shun, CT | 1 |
| Tai, HC | 1 |
| Huang, KH | 1 |
| Wang, SM | 1 |
| Lee, YJ | 1 |
| Kanaan, N | 1 |
| Cosyns, JP | 2 |
| Jadoul, M | 2 |
| Goffin, E | 1 |
| Laing, C | 1 |
| Hamour, S | 1 |
| Sheaff, M | 1 |
| Miller, R | 1 |
| Woolfson, R | 1 |
| Shibutani, S | 1 |
| Miller, F | 1 |
| Moll, U | 1 |
| Suzuki, N | 1 |
| Fernandes, A | 1 |
| Rosenquist, T | 1 |
| Medverec, Z | 1 |
| Jakovina, K | 1 |
| Brdar, B | 1 |
| Goodenough, AK | 1 |
| Rieger, R | 1 |
| Vukelić, M | 1 |
| Squifflet, JP | 1 |
| Wese, FX | 1 |
| van Ypersele de Strihou, C | 1 |
| De Broe, ME | 1 |
| Lord, GM | 1 |
| Cook, T | 1 |
| Schmeiser, HH | 1 |
| Williams, G | 1 |
| Pusey, CD | 1 |
| Debelle, FD | 1 |
| De Prez, EG | 1 |
| Garbar, CH | 1 |
| Vienne, AR | 1 |
| Salmon, IJ | 1 |
| Deschodt-Lanckman, MM | 1 |
| Lampert, N | 1 |
| Xu, Y | 1 |
| Nortier, J | 1 |
5 reviews available for aristolochic acid i and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
Topics: Aristolochic Acids; Carcinogens; Carcinoma, Transitional Cell; DNA Adducts; Drugs, Chinese Herbal; F | 2023 |
Recent advances in upper tract urothelial carcinomas: From bench to clinics.
Topics: Animals; Antineoplastic Agents; Aristolochic Acids; Arsenic; Carcinogens; Carcinoma, Transitional Ce | 2019 |
Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.
Topics: Animals; Aristolochia; Aristolochic Acids; Balkan Nephropathy; Carcinogens; Carcinoma, Transitional | 2019 |
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
Topics: Aristolochic Acids; Carcinoma, Transitional Cell; Colorectal Neoplasms, Hereditary Nonpolyposis; Hum | 2017 |
Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.
Topics: Aristolochic Acids; Balkan Nephropathy; Carcinoma, Transitional Cell; Diet; DNA Adducts; Endemic Dis | 2011 |
23 other studies available for aristolochic acid i and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
Topics: Aristolochic Acids; Biomarkers, Tumor; Carcinoma, Transitional Cell; Exome; Follow-Up Studies; Gene | 2022 |
Aristolochic acid: What urologists should know.
Topics: Aristolochic Acids; Carcinoma, Transitional Cell; Humans; Urinary Bladder Neoplasms; Urologists | 2022 |
De novo upper tract urothelial carcinoma after renal transplantation: a single-center experience in China.
Topics: Carcinoma, Transitional Cell; Humans; Kidney Transplantation; Neoplasm Recurrence, Local; Prognosis; | 2023 |
Aristolochic acid induces an inflammatory response with prostaglandin E2 production and apoptosis in NRK-52E proximal tubular cells.
Topics: Animals; Apoptosis; Aristolochic Acids; Carcinoma, Transitional Cell; Cell Line; Cyclooxygenase 2; D | 2023 |
Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.
Topics: Adult; Carcinoma, Transitional Cell; Cohort Studies; Female; Humans; Kidney Neoplasms; Male; Middle | 2023 |
Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.
Topics: Carcinoma, Transitional Cell; Cohort Studies; Humans; Incidence; Taiwan; Urinary Bladder Neoplasms; | 2023 |
Topics: Balkan Nephropathy; Carcinoma, Transitional Cell; Female; Glutathione Peroxidase; Humans; Kelch-Like | 2023 |
Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.
Topics: Aged; Aristolochic Acids; Carcinogens; Carcinoma, Transitional Cell; China; Female; Humans; Kaplan-M | 2014 |
A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.
Topics: Adult; Aged; Aristolochic Acids; Carcinoma, Transitional Cell; China; Cystectomy; Drugs, Chinese Her | 2015 |
De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Topics: Adult; Aged; Antiviral Agents; Aristolochic Acids; Cadaver; Carcinoma, Transitional Cell; China; Fem | 2009 |
Aristolochic acid-associated urothelial cancer in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional C | 2012 |
Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome.
Topics: Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Fema | 2012 |
Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinoma, Transitional Cell; China; Female; Hum | 2012 |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Topics: Adenine; Adult; Age Factors; Aged; Aged, 80 and over; Aristolochic Acids; Carcinogens; Carcinoma, Tr | 2013 |
The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency.
Topics: Aged; Aristolochic Acids; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Female; Humans; Kidne | 2003 |
Chinese herbal uropathy and nephropathy.
Topics: Adult; Aristolochic Acids; Carcinogens; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Humans; | 2006 |
Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Topics: Aristolochic Acids; Balkan Nephropathy; Carcinoma, Transitional Cell; DNA Adducts; Female; Humans; K | 2007 |
Urothelial lesions in Chinese-herb nephropathy.
Topics: Adult; Aristolochic Acids; Carcinogens; Carcinoma in Situ; Carcinoma, Transitional Cell; Drugs, Chin | 1999 |
On a nephrotoxic and carcinogenic slimming regimen.
Topics: Analgesics; Animals; Aristolochic Acids; Balkan Nephropathy; Carcinogens; Carcinoma, Transitional Ce | 1999 |
Urothelial malignant disease and Chinese herbal nephropathy.
Topics: Aristolochic Acids; Carcinogens; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Female; Humans | 2001 |
Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.
Topics: Animals; Aristolochic Acids; Body Weight; Carcinoma, Transitional Cell; Dose-Response Relationship, | 2002 |
Chinese herbal nephropathy.
Topics: Aristolochic Acids; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Humans; Kidney Failure, Chr | 2002 |
[Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)].
Topics: Anti-Obesity Agents; Aristolochia; Aristolochic Acids; Atrophy; Biomarkers; Carcinogens; Carcinoma, | 2002 |